Search

McKesson Corp

Geschlossen

BrancheGesundheitswesen

813.84 -1.63

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

807.73

Max

838.09

Schlüsselkennzahlen

By Trading Economics

Einkommen

432M

1.7B

Verkäufe

-9.9B

96B

KGV

Branchendurchschnitt

21.933

62.58

EPS

11.69

Dividendenrendite

0.38

Gewinnspanne

1.747

Angestellte

41,600

EBITDA

417M

2.3B

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+14.95% upside

Dividenden

By Acuity

Dividendenrendite

Branchendurchschnitt

0.38%

2.19%

Nächstes Ergebnis

5. Aug. 2026

Nächste Dividendenausschüttung

1. Okt. 2026

Nächstes Ex-Dividendendatum

1. Sept. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-1.6B

97B

Vorheriger Eröffnungskurs

815.47

Vorheriger Schlusskurs

813.84

Nachrichtenstimmung

By Acuity

51%

49%

259 / 340 Ranking in Healthcare

McKesson Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

22. Juli 2026, 19:31 UTC

News
Social Media

McKesson Corp raised its quarterly dividend to $0.94 per share and saw a price target increase to $955, but shares are lower today amid broader sector declines.

21. Juli 2026, 23:02 UTC

McKesson Corp shares declined in after-hours trading, though they remain above their 20-day moving average and near the upper end of their one-month range.

20. Juli 2026, 23:02 UTC

McKesson Corp shares are higher in after-market trading, reflecting upward momentum despite no specific news driving the price movement.

Peer-Vergleich

Kursveränderung

McKesson Corp Prognose

Kursziel

By TipRanks

14.95% Vorteil

12-Monats-Prognose

Durchschnitt 935.73 USD  14.95%

Hoch 1,050 USD

Tief 812 USD

Basierend auf 12 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für McKesson Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

12 ratings

11

Buy

1

Halten

0

Sell

Stimmung

By Acuity

259 / 340 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat